Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LAMTOR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDK5RAP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC12A9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR4746 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX7A2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC2A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SULT1A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EHD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TGOLN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LXN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PURA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM216 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MPND - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFV1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASAL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPPL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BBX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANXA11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on